Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Breast Neoplasms 2419Neoplasms 1838Carcinoma, Non-Small-Cell Lung 1591Prostatic Neoplasms 1296Colorectal Neoplasms 1117Lung Neoplasms 981Neoplasm Metastasis 828Multiple Myeloma 793Leukemia, Myeloid, Acute 773Ovarian Neoplasms 673Pancreatic Neoplasms 667Melanoma 660Squamous Cell Carcinoma of Head and Neck 589Recurrence 563Carcinoma, Hepatocellular 562Brain Neoplasms 515Glioblastoma 505Stomach Neoplasms 501Head and Neck Neoplasms 492Triple Negative Breast Neoplasms 471Lymphoma 460Uterine Cervical Neoplasms 444Carcinoma, Renal Cell 426Precursor Cell Lymphoblastic Leukemia-Lymphoma 420Lymphoma, Non-Hodgkin 387Endometrial Neoplasms 377Sarcoma 365Lymphoma, Follicular 357Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 355

Interventions

Inositol 2salicylsalicylic acid 1maltodextrin 1Sodium Salicylate 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Anovulation × 1 year × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

NCT07159880 2025-11-28

PROLEx-PCOS

EMBRIONARE

Phase NA Recruiting
20 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT03667443 2025-07-11

Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

Lo.Li.Pharma s.r.l

Phase NA Completed
50 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡